We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.04B
AUM Growth
+$198M
Cap. Flow
+$14M
Cap. Flow %
1.35%
Top 10 Hldgs %
42.78%
Holding
150
New
56
Increased
28
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$12.9M
2
LHCG
LHC Group LLC
LHCG
+$9.74M
3
CNMD icon
CONMED
CNMD
+$7.65M
4
LIVN icon
LivaNova
LIVN
+$7.59M
5
IMVT icon
Immunovant
IMVT
+$5.8M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.47M
2
XLRN
Acceleron Pharma
XLRN
+$5.43M
3
STAA icon
STAAR Surgical
STAA
+$5.36M
4
QDEL icon
QuidelOrtho
QDEL
+$5.09M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 38.45%
2 Industrials 1.39%
3 Energy 1.11%
4 Consumer Discretionary 0.31%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PROF
26
Profound Medical
PROF
$254M
$9.72M 0.93%
573,556
+31,300
+6% +$395K
RCM
27
DELISTED
R1 RCM Inc. Common Stock
RCM
$9.65M 0.93%
865,844
-208,099
-19% -$2.14M
QTNT
28
DELISTED
Quotient Limited Ordinary Shares
QTNT
$9.4M 0.9%
31,761
-10,255
-24% -$2.95M
FXH icon
29
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$9.2M 0.88%
102,000
-228,000
-69% -$19.5M
ZBH icon
30
Zimmer Biomet
ZBH
$18.5B
$8.91M 0.86%
76,892
-37,286
-33% -$4.3M
NVRO
31
PUT
DELISTED
NEVRO CORP.
NVRO
$8.48M 0.82%
+71,000
New +$8.42M
ABT icon
32
PUT
Abbott
ABT
$190B
$8.41M 0.81%
+92,000
New +$8.32M
SRPT icon
33
CALL
Sarepta Therapeutics
SRPT
$1.92B
$8.18M 0.79%
51,000
+1,000
+2% +$136K
CNMD icon
34
CONMED
CNMD
$1.48B
$7.91M 0.76%
+109,900
New +$7.65M
SIBN icon
35
SI-BONE Inc
SIBN
$843M
$7.55M 0.73%
473,703
-42,773
-8% -$674K
KIDS icon
36
OrthoPediatrics
KIDS
$633M
$7.53M 0.72%
172,113
+23,600
+16% +$1.06M
LIVN icon
37
LivaNova
LIVN
$4.33B
$7.29M 0.7%
+151,473
New +$7.59M
INOV
38
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$6.87M 0.66%
356,600
-118,400
-25% -$2.1M
IMVT icon
39
Immunovant
IMVT
$8.45B
$6.59M 0.63%
+270,806
New +$5.8M
BSX icon
40
Boston Scientific
BSX
$74.2B
$6.44M 0.62%
183,500
+58,500
+47% +$2.11M
DMTK
41
DELISTED
DermTech, Inc. Common Stock
DMTK
$6.23M 0.6%
471,143
+162,227
+53% +$2.11M
NVTA
42
CALL
DELISTED
Invitae Corporation
NVTA
$6.21M 0.6%
+205,000
New +$3.58M
MDT icon
43
PUT
Medtronic
MDT
$116B
$5.82M 0.56%
+63,500
New +$6.09M
OSUR icon
44
OraSure Technologies
OSUR
$268M
$5.65M 0.54%
485,600
+350,579
+260% +$4.55M
ICUI icon
45
CALL
ICU Medical
ICUI
$4.55B
$5.53M 0.53%
30,000
-91,500
-75% -$18.2M
MRK icon
46
Merck
MRK
$322B
$5.34M 0.51%
+72,437
New +$5.45M
INCY icon
47
CALL
Incyte
INCY
$24.5B
$5.3M 0.51%
+51,000
New +$4.92M
IMMU
48
DELISTED
Immunomedics Inc
IMMU
$5.16M 0.5%
+145,445
New +$4.25M
GH icon
49
Guardant Health
GH
$22.2B
$5.1M 0.49%
62,900
+8,425
+15% +$679K
SILK
50
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$4.98M 0.48%
+118,900
New +$4.56M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Pura Vida Investments held 150 positions worth $1.04B, up 23% from $842M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments's Q2 2020 filing shows 56 new, 28 increased, 29 reduced and 29 closed positions. Its largest new stake was LHC Group LLC: 66,359 shares worth $11.6M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.47M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Industrials and Energy.

  • Pura Vida Investments's largest Q2 2020 buy was LHC Group LLC: 66,359 shares worth $11.6M.
  • Pura Vida Investments added most to AtriCure in Q2 2020, an estimated $12.9M increase.
  • Pura Vida Investments's biggest Q2 2020 reduction was Acceleron Pharma, cutting an estimated $5.43M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $5.47M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $1.04B portfolio in Q2 2020.
  • Pura Vida Investments opened 56 new positions and closed 29 in Q2 2020.
  • Pura Vida Investments's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.